Anesthesia issues in the perioperative management of myasthenia gravis

Seminars in Neurology

Volumn 24, Issue 1, 2004, Pages 83-94

  Dillon, Francis X ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticholinesterase; Mechanical ventilation; Myasthenia gravis; Neuromuscular blocking drug; Nondepolarizing muscle relaxant; Succinylcholine

Indexed keywords

ANESTHETIC AGENT; ANTIMETABOLITE; ATROPINE; AZATHIOPRINE; CHOLINESTERASE INHIBITOR; CISATRACURIUM; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EDROPHONIUM; GLYCOPYRRONIUM BROMIDE; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MIVACURIUM; MUSCLE RELAXANT AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PREDNISONE; PYRIDOSTIGMINE; RITUXIMAB; ROCURONIUM; SEDATIVE AGENT; SUXAMETHONIUM; UNCLASSIFIED DRUG;

ALLERGY; ANESTHESIA; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ANESTHETIC RECOVERY; ARTIFICIAL VENTILATION; ASEPTIC MENINGITIS; AUTOIMMUNE DISEASE; BLOOD VISCOSITY; BONE MARROW SUPPRESSION; BRADYCARDIA; CANCER; CAREGIVER; DEVICE; ENDOTRACHEAL INTUBATION; EXTUBATION; FAMILY; HEADACHE; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; INFECTION; INTERPERSONAL COMMUNICATION; INTESTINE SECRETION; LIVER TOXICITY; MIGRAINE; MONITORING DEVICE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYOPATHY; NAUSEA; NEUROMUSCULAR JUNCTION DISORDER; PATIENT MONITORING; PERIOPERATIVE PERIOD; PLASMAPHERESIS; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; STOMATITIS; TERATOGENESIS; THROMBOEMBOLISM; THYMECTOMY; TREATMENT PLANNING; TREMOR; UPPER RESPIRATORY TRACT INFECTION; VASCULAR ACCESS; VASCULAR DISEASE;

ANESTHESIA; ELECTRIC STIMULATION; HUMANS; HYPNOTICS AND SEDATIVES; MONITORING, PHYSIOLOGIC; MYASTHENIA GRAVIS; NEUROMUSCULAR BLOCKING AGENTS; PERIOPERATIVE CARE; RESPIRATION, ARTIFICIAL;

EID: 3042641202     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-829587     Document Type: Review

References (55)

1. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330:1797-1810
2. Eisenkraft JB, Book WJ, Mann SM, et al. Resistance to succinylcholine in myasthenia gravis: a dose-response study. Anesthesiology 1988;69:760-763
3. Mann R, Blobner M, Jelen-Esselborn S, et al. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients. Anesthesiology 2000;93:346-350
4. Leventhal R, Orkin F, Hirsch R. Prediction of the need for postoperative mechanical ventilation in myasthenia gravis. Anesthesiology 1980;53:26-30
5. Vareles PN, Chua HC, Natterman J. Ventilatory care in myasthenia gravis crisis: assessing the baseline adverse event rate. Crit Care Med 2002;30:2663-2668
6. Lucchi M, Mussi A, Ricciardi R, et al. Thymectomy in ocular myasthenia gravis. J Thorac Cardiovasc Surg 2003;125:740-741
7. Evoli A, Batocchi AP, Minisci C, et al. Clinical characteristics and prognosis of myasthenia gravis in older people. J Am Geriatr Soc 2000;48:1442-1448
8. Nakagawa K, Asamura H, Matsuno Y, et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003; 126:1134-1140
9. Poulas K, Tsibri E, Kokla A, et al. Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 2001;71:352-356
10. Chitnis T, Khoury SJ. Immunologic neuromuscular disorders. J Allergy Clin Immunol 2003;111:S659-S668
11. Carding P. Voice pathology in the United Kingdom. BMJ 2003;327:514-515
12. Fried MJ, Protheroe T. d-Penicillamine induced myasthenia gravis: its relevance for the anesthetist. Br J Anaesth 1986;58:1191-1193
13. Calhoun RF, Ritter JH, Guthrie TJ, et al. Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients. Ann Surg 1999;230:555-561
14. Hart N, Simonds AK. The pulmonary physician in critical care. Illustrative case 4: neuromusculoskeletal disorders. Thorax 2003;58:547-549
15. Wittbrodt ET. Drugs and myasthenia gravis: an update. Arch Intern Med 1997;157:399-408
16. Kokontis L, Gutmann L. Current treatment of neuromuscular diseases. Arch Neurol 2000;57:939-943
17. Kupersmith MJ, Latkany R, Homel P. Development of generalized disease at 2 years in patients with ocular myasthenia gravis. Arch Neurol 2003;60:243-248
18. Miller RG, Milner-Brown HS, Mirka A. Prednisone-induced worsening of neuromuscular function in myasthenia gravis. Neurology 1986;36:729-732
19. Ciafaloni E, Nikhar NK, Massey JM, et al. Retrospective analysis of the use of cyclosporine in myasthenia gravis. Neurology 2000;55:448-450
20. Meriggioli MN, Ciafaloni E, Al-Hayk KA, et al. Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability. Neurology 2003;61:1438-1440
21. Bathon JM, Martin JW, Fleishman RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-1593
22. Dalakas MC. Mechanisms of action of IVIG and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology 2002;59:S13-S21
23. Wylam ME, Anderson PM, Kuntz NL, et al. Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report. J Pediatr 2003;143:674-677
24. Newsom-Davis J, Vincent A, Wilson SG, et al. Long term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979;1:464-468
25. Gronset G, Barohn R. Practice parameter: thymectomy for autoimmune myasthenia gravis. Neurology 2000;55:7-15
26. Ruff RL, Batchelor TT, Taylor LP, et al. Steroid myopathy in cancer patients. Neurology 1997;48:1234-1238
27. Ruff RL. Acute illness myopathy. Neurology 1996;46:600-601
28. Gutmann L, Blumenthal D, Schochet SS. Acute type II myofiber atrophy in critical illness. Neurology 1996;46:819-821
29. Rich MM, Teener JW, Raps EC, et al. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996; 46:731-736
30. Eisenkraft JB, Papatestas AE, Kahn CH, et al. Predicting the need for postoperative mechanical ventilation in myasthenia gravis. Anesthesiology 1986;65:79-82
31. Erlacher W, Kontaratos M, Muller C, et al. Intubation without muscle relaxation: alfentanil/propofol as an alternative induction regime for children. Anesthesiology 1998; 89(suppl):1316A
32. Bell CF, Florence AM, Hunter JM, et al. Atracurium in the myasthenic patient. Anaesthesia 1984;39:961-968
33. Hunter JM, Bell CF, Florence AM, et al. Vecuronium in the myasthenic patient. Anaesthesia 1985;40:848-853
34. Rowlee S. Monitoring neuromuscular blockade in the intensive care unit: the peripheral nerve stimulator. Heart Lung 1999;28:352-362
35. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in non-cardiac surgical procedures. N Engl J Med 1977;297:845-850
36. Ely EW, Baker AM, Dunagan DP, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996;335:1864-1869
37. Esteban A, Frutos F, Tobin MJ, et al. A comparison of four methods of weaning patients from mechanical ventilation. N Engl J Med 1995;332:345-350
38. Adrogué HJ, Madias NE. Management of life-threatening acid-base disorders, I and II. N Engl J Med 1998;338:26-34107-111
39. Yende S, Wunderink R. Causes of prolonged mechanical ventilation after coronary artery bypass surgery. Chest 2002; 122:245-252
40. Adnet F, Baud F. Relation between Glasgow Coma Scale and aspiration pneumonia. Lancet 1996;348:123-124
41. Kim K, Lew S, Cho HY, et al. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. Anesth Analg 2002;95:1656-1660
42. Gennari FJ. Hypokalemia. N Engl J Med 1998;339:451-458
43. Subramanian R, Khardori RM. Severe hypophosphatemia: pathophysiologic implications, clinical presentations, and treatment. Medicine (Baltimore) 2000;79:1-8
44. Oelkers W. Adrenal insufficiency. N Engl J Med 1996;335:1206-1212
45. Nair SR, Pearson SB. Mucous plug in the bronchus causing lung collapse. N Engl J Med 2002;347:1079
46. Fawcett WJ, Stone JP. Recurarization in the recovery room following the use of magnesium sulphate. Br J Anaesth 2003; 91:435-438
47. McDonald CM. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil 2002;81:S108-S120
48. Ashworth SF, Cordingly JJ. New modes of ventilation. Curr Anesth Crit Care 2003;14:90-99
49. Vivien B, Di Maria S, Ouattara A, et al. Overestimation of bispectral index in sedated intensive care unit patients revealed by administration of muscle relaxant. Anesthesiology 2003; 99:9-17
50. Messner M, Beese U, Romstöck JK. The bispectral index declines during neuromuscular block in fully awake persons. Anesth Analg 2003;97:488-491
51. Antonelli M, Conti G, Rocco M, et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998;339:429-435
52. Hart N, Simonds AK. The pulmonary physician in critical care. Illustrative case 4: neuromusculoskeletal disorders. Thorax 2003;58:547-549
53. Rabinstein A, Wijdicks EFM. BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology 2002;59:1647-1649
54. Djelmis J, Sostarko M, Mayer D, et al. Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol 2002;104:21-25
55. Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology 2003;61:1362-1366